1. Home
  2. LRMR vs BZUN Comparison

LRMR vs BZUN Comparison

Compare LRMR & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • BZUN
  • Stock Information
  • Founded
  • LRMR N/A
  • BZUN 2007
  • Country
  • LRMR United States
  • BZUN China
  • Employees
  • LRMR N/A
  • BZUN N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • BZUN Catalog/Specialty Distribution
  • Sector
  • LRMR Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • LRMR Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • LRMR 183.8M
  • BZUN 188.7M
  • IPO Year
  • LRMR N/A
  • BZUN N/A
  • Fundamental
  • Price
  • LRMR $2.07
  • BZUN $2.78
  • Analyst Decision
  • LRMR Strong Buy
  • BZUN Buy
  • Analyst Count
  • LRMR 10
  • BZUN 2
  • Target Price
  • LRMR $19.60
  • BZUN $3.20
  • AVG Volume (30 Days)
  • LRMR 911.3K
  • BZUN 257.6K
  • Earning Date
  • LRMR 03-24-2025
  • BZUN 03-20-2025
  • Dividend Yield
  • LRMR N/A
  • BZUN N/A
  • EPS Growth
  • LRMR N/A
  • BZUN N/A
  • EPS
  • LRMR N/A
  • BZUN N/A
  • Revenue
  • LRMR N/A
  • BZUN $1,290,875,449.00
  • Revenue This Year
  • LRMR N/A
  • BZUN $5.59
  • Revenue Next Year
  • LRMR N/A
  • BZUN $4.40
  • P/E Ratio
  • LRMR N/A
  • BZUN N/A
  • Revenue Growth
  • LRMR N/A
  • BZUN 6.92
  • 52 Week Low
  • LRMR $2.07
  • BZUN $2.11
  • 52 Week High
  • LRMR $11.20
  • BZUN $4.38
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 31.08
  • BZUN 34.32
  • Support Level
  • LRMR $2.19
  • BZUN $2.69
  • Resistance Level
  • LRMR $2.44
  • BZUN $3.08
  • Average True Range (ATR)
  • LRMR 0.18
  • BZUN 0.14
  • MACD
  • LRMR -0.01
  • BZUN -0.06
  • Stochastic Oscillator
  • LRMR 5.19
  • BZUN 6.04

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About BZUN Baozun Inc.

Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).

Share on Social Networks: